drugset / Trial / NCT02840097

Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: A Pilot and Feasibility Study

NCT02840097

RandomizedParallel-groupTriple-blindTreatment

Summary

Trauma is the leading cause of death and disability in children in the United States. The long-term goal of this project is to evaluate the benefits and harms of tranexamic acid (TXA; a drug that stops bleeding) in severely injured children. This is a 40-patient pilot study to evaluate the feasibility of two subsequent large-scale studies of TXA in injured children.

Timeline

Start
2019-03-04
Primary completion
2020-10-03
Completion
2020-10-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 2 mg/kg
Subject Tranexamic Acid Small molecule 4 mg/kg